ArticleScientific reports2026
ABCC6 pathogenic variants are associated with hemorrhagic phenotypes in Japanese patients with severe cerebral small vessel disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ABCC6 in Cellular Metabolic Homeostasis: Biochemical Links to Extracellular Nucleotide Signaling, Mitochondrial Stress, and Senescence.Cell biochemistry and biophysics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
ABCC6 pathogenic variants affect ischemic and hemorrhagic lesions in multiple organs and represent the third most common cause of hereditary cerebral small vessel diseases (CSVD) in Japan, yet their CSVD phenotypes remains unclear. We conducted a multicenter, cross-sectional study of 158 consecutive Japanese adults with severe CSVD. Genetic analysis was performed, and clinical and brain MRI findings were compared among ABCC6-related CSVD, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and genetically undetermined CSVD. Univariate and multivariate analyses assessed the association between ABCC6 pathogenic variants and hemorrhagic stroke, adjusting for age and hypertension. Nine patients (5.7%) carried pathogenic heterozygous ABCC6 variants. Hemorrhagic stroke was more frequent in ABCC6-related CSVD than in CADASIL (55.6% vs 13.6%, P = 0.039) and undetermined CSVD (55.6% vs 10.3%, P = 0.010). Multivariate analysis confirmed an independent association (odds ratio 8.4, 95% CI 2.0-38.4, P = 0.004). On MRI, ABCC6-related CSVD showed fewer anterior temporal lesions but more multiple microbleeds than CADASIL. The direction of these findings remained consistent when biallelic cases were included. These findings indicate a distinct, hemorrhage-predominant CSVD phenotype associated with ABCC6 in Japanese patients, support a contributory role of ABCC6, and warrant validation in larger, multi‑ethnic cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.